Frog-Derived Antimicrobial Peptide Calms Inflammation in Immune Cells | Research

The takeaway

QsCATH, a cathelicidin peptide from the Chinese spiny frog, suppressed pro-inflammatory pathways in macrophages by inhibiting NF-κB and TNF signaling.

NF-κB inhibition
QsCATH from Chinese spiny frog suppresses key inflammatory signaling pathways in macrophages

What the researchers found

QsCATH suppressed pro-inflammatory cytokines and NF-κB/TNF pathways in macrophages, confirmed by transcriptomics and molecular docking.

Why it matters

Natural anti-inflammatory peptides from amphibians could inspire new drugs that fight infection and calm inflammation simultaneously.

The numbers in context

Downregulated tnf, il6, ccl5, il1b; suppressed NF-kB, TNF, and NOD-like receptor pathways; tested in RAW264.7 macrophages.

How the study worked

RNA sequencing of QsCATH-treated RAW264.7 macrophages with KEGG/GO enrichment and molecular docking analysis.

Who was studied

N/A (RAW264.7 macrophage cell line)

What this study cannot tell us

In vitro cell culture study — in vivo efficacy, toxicity, and pharmacokinetics are unknown.

How to read the evidence

In vitro transcriptomic study with computational validation — strong mechanistic data but preclinical.

When this study was published

Published in 2025, advancing amphibian-derived peptide research.

The bigger picture

Amphibian peptides are an untapped reservoir of dual-function molecules — antimicrobial plus anti-inflammatory — with therapeutic potential.

Questions still open

Could QsCATH be developed as an anti-inflammatory drug?
Do other frog cathelicidins share these immunomodulatory properties?

Common questions

Can frog peptides reduce inflammation?

QsCATH from the Chinese spiny frog effectively suppressed inflammatory signaling in immune cells, suggesting potential for anti-inflammatory drug development.

What are cathelicidins?

A family of antimicrobial peptides found across vertebrates that kill bacteria and modulate immune responses — frogs are a rich source of novel variants.

Read the original research

Immunomodulatory effects of QsCATH on macrophages: transcriptomic insights and molecular docking analysis.

Scientific reports, 15(1), 43728

View on PubMed ↗Publisher’s paper ↗

Citation

Qiao, Fen; Qian, Xin-Yi; Wu, Jia-Le; Wang, Zi-Xuan; Feng, Yi-Kai; Chen, Jie. (2025). Immunomodulatory effects of QsCATH on macrophages: transcriptomic insights and molecular docking analysis.. Scientific reports, 15(1), 43728. https://doi.org/10.1038/s41598-025-28482-9